Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005 - Wikidata - awgldk - TriplyDB

Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005

Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005

http://www.wikidata.org/entity/Q36930643

about

Common polymorphisms influencing serum uric acid levels contribute to susceptibility to gout, but not to coronary artery disease Gout--current diagnosis and treatment Lesinurad in combination with allopurinol: results of a phase 2, randomised, double-blind study in patients with gout with an inadequate response to allopurinol 2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative Gout and Risk of Myocardial Infarction: A Systematic Review and Meta-Analysis of Cohort Studies Increased cardiovascular mortality associated with gout: a systematic review and meta-analysis Health-related quality of life in gout: a systematic review Systematic review and meta-analysis of the clinical efficacy and adverse effects of Chinese herbal decoction for the treatment of gout Functional and Structural Characterization of Purine Nucleoside Phosphorylase from Kluyveromyces lactis and Its Potential Applications in Reducing Purine Content in Food Association between SLC2A9 (GLUT9) gene polymorphisms and gout susceptibility: an updated meta-analysis.Ultrafiltration liquid chromatography combined with high-speed countercurrent chromatography for screening and isolating potential α-glucosidase and xanthine oxidase inhibitors from Cortex Phellodendri.Prescription and comorbidity screening following consultation for acute gout in primary care.Association of common polymorphisms in GLUT9 gene with gout but not with coronary artery disease in a large case-control study.The association between thyroid disorders and incident gout: population-based case-control study.Hyperuricemia and incident heart failure.The prevalence of rheumatic diseases in central Greece: a population survey.Gout in immigrant groups: a cohort study in Sweden Serum apoprotein A1 levels are inversely associated with disease activity in gout: From a southern Chinese Han population.Prevention of comorbidity and acute attack of gout by uric acid lowering therapy Seasonal variations of urate in a Swedish adult population Chuanhu anti-gout mixture versus colchicine for acute gouty arthritis: a randomized, double-blind, double-dummy, non-inferiority trial.Clinical and health care use characteristics of patients newly starting allopurinol, febuxostat, and colchicine for the treatment of gout.Risk factors for gout and prevention: a systematic review of the literature.Epidemiology of gout.Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia.Uric acid and evolution.Comorbidities in patients with crystal diseases and hyperuricemia.Urate lowering therapy with febuxostat in daily practice-a multicentre, open-label, prospective observational study.2011 recommendations for the diagnosis and management of gout and hyperuricemia.Orthopaedic case of the month: medial knee pain in a 69-year-old man.Prospective observational cohort study of Health Related Quality of Life (HRQOL), chronic foot problems and their determinants in gout: a research protocol An old disease with new insights: Update on diagnosis and treatment of gout.The association of gout with sleep disorders: a cross-sectional study in primary care.Association of TLR4 Gene rs2149356 polymorphism with primary gouty arthritis in a case-control study.Large epidemiologic studies of gout: challenges in diagnosis and diagnostic criteria.Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases.New and improved strategies for the treatment of gout Advances in the management of gout: critical appraisal of febuxostat in the control of hyperuricemia.Familial aggregation of gout and relative genetic and environmental contributions: a nationwide population study in Taiwan Revisiting the pathogenesis of podagra: why does gout target the foot?

P2860

Q21091170-A4E27F0C-97BD-4810-8E7C-96841A729122 Q24644156-8E621837-3247-4378-81E0-893D18432782 Q24658504-C16A6B2E-15B2-4C67-ADF9-C037EF76DEBA Q26781632-F9DC8E6D-8934-43F2-B7B4-F3BE4B6E4AE4 Q26800933-74B35997-7179-4CF5-AC76-75391A0D5C70 Q27000643-7F8392A1-387D-421E-B6EC-1F8D5F893E1F Q27690739-2999F10E-073A-4546-BB93-9C68823EA321 Q28538903-DCABDDCE-20E6-49EA-ADCF-0E73C2CB08F0 Q28552877-82F39980-9A31-419A-BC4A-257DF19AE64B Q30250018-22F2206D-D5B1-432B-80D6-1CFE529FD1D2 Q30833906-E9F0A8EC-1555-43F3-A72B-592D45F2B0E5 Q30888155-D3172A91-D7B2-46FF-97DC-92C77BE805D6 Q33327367-913F0D71-5267-4DC5-A5AF-7684EF4D1DB2 Q33553496-4C03407A-E053-48C3-AF8C-CAE89457CA90 Q33572047-9C0AE391-1E75-4422-947F-47A3946AD225 Q33588016-CAFDD623-411E-4A75-9E9D-D0E10C1E782F Q33592015-46FE1B3B-9899-4991-B34E-29A55432B7D1 Q33627261-7512D2E5-6DA7-47FE-B2DB-BE48A3697ACA Q33627488-275D20A0-D478-4554-B4B0-354B0F00BD6D Q33840512-61217E7D-6F60-49B3-AD6D-0C625B083F09 Q33843844-815CA2F6-5CAE-4B59-AF56-BB9F48A3D8C9 Q33896768-CCC41833-A903-4C5A-AB61-8AD91B9FE47F Q33924627-ABBD794A-D433-41AF-B4FD-E53902DDD00F Q33993424-FB81DE44-3C5C-44EF-B859-920C251F3FB0 Q33996337-AFD4160A-EC16-49A3-972D-1F3684CCE094 Q34125842-3D4D8F53-107C-4657-90D7-4929EB3F1A15 Q34157725-FA7A9672-553D-400C-9EDC-0541FB40DECA Q34207190-D448894F-D70C-4004-A83E-C6CC1722AFF1 Q34250995-7CBEEEA6-B437-4D61-86AA-9E02CEFBEF7B Q34434947-CEBED99B-48A0-439D-96D0-544A5C237807 Q34475643-9160D09D-6B3E-4A37-9FAE-6A077020826F Q34542091-A09B49B9-F277-4518-BE0B-04081DDEFB2A Q34655021-2903171A-56B1-4AB0-8381-CF4FAFE18F2B Q34758946-770E0548-5DFD-4FCC-AE16-21C187195BB9 Q34975884-6DA53CEF-44E2-4AEA-800F-5D2E7B100A39 Q34986307-C4488F17-DBDE-408F-A346-FCB29F350C59 Q35026692-8F5AA14F-08F7-4BD4-8AE9-1834B1464C5C Q35026721-73476290-D76F-45BF-BC9E-2DE1C3CE82C4 Q35048342-A696E9AF-430C-4B14-84E2-2D8445C8DAD8 Q35052925-77795A24-3132-4B24-B6E9-F629783A8947

P2860

Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005

http://www.wikidata.org/entity/Q36930643

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Gout in the UK and Germany: pr ...... in general practice 2000-2005

@en

type

label

Gout in the UK and Germany: pr ...... in general practice 2000-2005

@en

prefLabel

Gout in the UK and Germany: pr ...... in general practice 2000-2005

@en

P1433

Q36930643-C98D9734-3592-43C0-B548-FBE7F3AB46B8

P1476

Q36930643-FEE94E90-0426-4843-A2DE-A3EA26118E88

P2093

Q36930643-3866D253-5E97-4CBC-AD44-B586243E14CC

Q36930643-5F95C7B0-6764-489C-9ADB-E1ABEB8A55F3

Q36930643-64D0BE37-E975-417D-8840-C44C6F3FC24B

Q36930643-766F2793-DBFF-47F8-8B9D-4B2DFCBCD7B9

Q36930643-88C86C7F-0DEE-4A38-9C5F-0DE8E0719C1C

Q36930643-E910BD64-4FAD-4E9E-8EA1-9AE89F27800A

Q36930643-F89FC03F-5700-4AAB-A255-533FBE23C555

P2860

Q36930643-0A4AC68D-6ADC-44EA-9C2F-5A9D5909FC83

Q36930643-0A8CE57C-844A-4731-9426-F387238F6799

Q36930643-31331F36-E8CD-45ED-8064-519E386BD963

Q36930643-32067267-6C3C-4DC3-B46C-D79BBB7B3272

Q36930643-36A49B1D-35C5-4F62-AA1D-EE9D37705E67

Q36930643-38052B54-9E24-4253-83C6-EF68452B74F4

Q36930643-4EF0A9CA-00E4-4034-8351-BED8DAED55EB

Q36930643-4F1695D5-539E-4690-9BAD-A3F838ECB3E8

Q36930643-5E017163-5770-4FDD-AB81-C17063E4D29F

Q36930643-61588107-2080-4BA3-85EA-1270236C43FF

P304

Q36930643-8C243F1B-F0A4-4AF7-82DB-0714178D74A0

P31

Q36930643-7CCD6D4A-C832-4790-BFE8-3A405D82386D

P356

Q36930643-4117B41D-1CFC-4AFF-A0EE-4A570DADF8A6

P407

Q36930643-E63858A5-4C54-4B0E-8A50-CD38BD17B587

P433

Q36930643-B4D98745-45CC-4758-BABC-2C39D142277A

P478

Q36930643-2F64FFDA-C2FD-4230-9FBF-5BAA816D40C1

P577

Q36930643-DDE78610-6FEC-4C84-A492-1D8C765D4773

P5875

Q36930643-FF9150EF-D038-4E06-8F1D-CEFA6BB7A60E

P698

Q36930643-16300E7D-CDCF-4E23-B0EE-9405F261A6D3

P921

Q36930643-60B2FF82-9480-4EC4-B4F6-5CF790B31CFC

P932

Q36930643-49822CBA-8828-4038-92C7-63A774A98093

P356

ARD.2007.076232

P1433

Annals of the Rheumatic Diseases

P1476

Gout in the UK and Germany: pr ...... in general practice 2000-2005

@en

P2093

E Spaepen

http://www.w3.org/2001/XMLSchema#string

G Nuki

http://www.w3.org/2001/XMLSchema#string

L Annemans

http://www.w3.org/2001/XMLSchema#string

M Bonnemaire

http://www.w3.org/2001/XMLSchema#string

M Gaskin

http://www.w3.org/2001/XMLSchema#string

T Gilbert

http://www.w3.org/2001/XMLSchema#string

V Malier

http://www.w3.org/2001/XMLSchema#string

P2860

Pathogenesis of Gout

EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout

Gout and the risk of acute myocardial infarction

Prevalence of comorbid conditions and prescription medication use among patients with gout and hyperuricemia in a managed care setting

Serum urate levels and gout flares: analysis from managed care data.

Prevalence and incidence of the diagnosis of gout in Great Britain.

Clinical survey of 354 patients with gout.

Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study.

P304

960-966

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ARD.2007.076232

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

67

http://www.w3.org/2001/XMLSchema#string

P577

2007-11-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5864588

http://www.w3.org/2001/XMLSchema#string

P698

17981913

http://www.w3.org/2001/XMLSchema#string

P921

P932

2564789

http://www.w3.org/2001/XMLSchema#string